|
| Press Releases |
|
 |
|
| Wednesday, February 23, 2022 |
|
|
Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7% |
| Q&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group"), a leading private dental healthcare group in Asia, today reported the highest-ever revenue and profit after tax of S$205.6 million and S$39.4 million respectively for the financial year ended 31 December 2021 ("FY2021"). more info >> |
|
| Thursday, December 16, 2021 |
|
|
Acumen Diagnostics granted Ministry of Health COVID-19 offsite PCR testing license, up to 100 sites island-wide |
| Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group (Singapore) Limited ("Q&M Dental") and 49% owned by Aoxin Q&M Dental Group Limited ("Aoxin Q&M Dental"), today announced that it has been granted a license by the Ministry of Health, Singapore to provide offsite COVID-19 polymerase chain reaction ("PCR") swab services and serology sample collection. more info >> |
|
| Friday, December 3, 2021 |
|
|
Acumen Diagnostics' PCR capabilities to tackle Omicron COVID-19 variant |
| Homegrown medical technology Company, Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics" or the "Company"), a 51% owned subsidiary of Q&M Dental Group (Singapore) and 49% owned by Aoxin Q&M Dental, today announced that its proprietary, locally-manufactured polymerase chain reaction ("PCR") test kits Acu-Corona 2.0 and Acu-Corona Duplex are able to detect COVID-19 positive cases infected with the Omicron variant. more info >> |
|
| Thursday, November 11, 2021 |
|
|
Q&M Dental net profit surges 154% to S$35.4M for nine months ended 30 September 2021 |
| Q&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group"), a leading private dental healthcare group in Asia, today reported net profit after tax attributable to shareholders of S$27.3 million for the nine months ended 30 September 2021 ("9M2021"), and net profit after tax attributable to shareholders S$9.5 million for the three months ended 30 September 2021 ("3Q2021"). more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
百年金字招牌煥新顏：同仁堂醫養啟動招股 四大投資邏輯錨定"中醫醫療服務龍頭"
Mar 20, 2026 22:21 HKT/SGT
|
|
|
百年金字招牌焕新颜：同仁堂医养启动招股 四大投资逻辑锚定"中医医疗服务龙头"
Mar 20, 2026 22:21 HKT/SGT
|
|
|
FILMART and EntertainmentPulse draw about 8,000 industry participants
Mar 20, 2026 21:40: JST
|
|
|
FILMART and EntertainmentPulse draw about 8,000 industry participants
Mar 20, 2026 20:40 HKT/SGT
|
|
|
康哲藥業業績拐點確立：創新藥與獨家藥接棒增長 新藥進入密集兌現期
Mar 20, 2026 20:08 HKT/SGT
|
|
|
TANAKA Announces Executive Appointments
Mar 20, 2026 20:00 HKT/SGT
|
|
|
127家醫療企業排隊赴港 同仁堂醫養攜連年穩增營收開啟招股
Mar 20, 2026 18:15 HKT/SGT
|
|
|
127家医疗企业排队赴港 同仁堂医养携连年稳增营收开启招股
Mar 20, 2026 18:15 HKT/SGT
|
|
|
「国家新发展 香港新机遇 十五五开局研讨会」圆满结束 逾500名内地企业代表及港商共谋香港机遇
Mar 20, 2026 16:28 HKT/SGT
|
|
|
「國家新發展 香港新機遇 十五五開局研討會」圓滿結束 逾500名內地企業代表及港商共謀香港機遇
Mar 20, 2026 16:28 HKT/SGT
|
|
|
同仁堂醫養今日招股：萬億中醫賽道迎來行業龍頭 打造「醫養結合」新標杆
Mar 20, 2026 15:04 HKT/SGT
|
|
|
同仁堂医养今日招股：万亿中医赛道迎来行业龙头 打造"医养结合"新标杆
Mar 20, 2026 15:04 HKT/SGT
|
|
|
MarketingPulse and eTailingPulse attract more than 1,700 industry professionals
Mar 20, 2026 12:42: JST
|
|
|
MarketingPulse及eTailingPulse吸引逾1,700名业界人士参与 反应热烈 匯聚全球电商及品牌领袖 探讨AI、数据与美学智慧 打造新增长方程式
Mar 20, 2026 11:42 HKT/SGT
|
|
|
MarketingPulse及eTailingPulse吸引逾1,700名業界人士參與 反應熱烈 匯聚全球電商及品牌領袖 探討AI、數據與美學智慧 打造新增長方程式
Mar 20, 2026 11:42 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
